MedPath

广西鸿博药业有限公司

Ownership
-
Established
2004-01-08
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

57

NMPA:57

Drug Approvals

Cefalexin Capsules

Product Name
头孢氨苄胶囊
Approval Number
国药准字H45020418
Approval Date
Sep 30, 2020
NMPA

Chlorphenamine Maleate Tablets

Product Name
马来酸氯苯那敏片
Approval Number
国药准字H45020380
Approval Date
Aug 19, 2020
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H45020381
Approval Date
Aug 19, 2020
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H45020329
Approval Date
Aug 19, 2020
NMPA

Vitami B1 Tablets

Product Name
维生素B1片
Approval Number
国药准字H45020444
Approval Date
Aug 19, 2020
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H45020383
Approval Date
Aug 19, 2020
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H45020377
Approval Date
Aug 19, 2020
NMPA

Vitami B1 Tablets

Product Name
维生素B1片
Approval Number
国药准字H45020443
Approval Date
Aug 19, 2020
NMPA

穿心莲片

Approval Number
国药准字Z45020766
Approval Date
Aug 19, 2020
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H45020323
Approval Date
Aug 19, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.